HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Infestation by Macronyssidae — Clinical Guidelines

Overview

Macronyssidae infestation refers to parasitic infestations caused by mites belonging to the family Macronyssidae, commonly affecting mammals including livestock and occasionally humans. These mites typically reside in hair follicles or sebaceous glands, leading to dermatological issues such as pruritus, alopecia, and secondary infections. The clinical significance lies in the discomfort and potential economic losses in livestock, as well as the need for accurate diagnosis and management in human cases to prevent complications. Clinicians must recognize these infestations promptly to initiate appropriate treatment, minimizing patient discomfort and potential spread. 1 2

Pathophysiology

Macronyssidae mites invade the hair follicles or sebaceous glands of their hosts, establishing themselves within these protected environments. The mites feed on keratinized debris and skin secretions, causing mechanical irritation and inducing an inflammatory response from the host's immune system. This interaction leads to the characteristic symptoms of pruritus and skin lesions. Over time, chronic infestation can result in significant skin damage, including follicular damage and secondary bacterial infections due to breaks in the skin barrier. The inflammatory cascade triggered by mite activity can also exacerbate allergic reactions, further complicating the clinical presentation. 1 2

Epidemiology

The incidence of Macronyssidae infestations varies by species and geographic region. In livestock, particularly in cattle and sheep, these infestations are relatively common, especially in crowded or unsanitary conditions. Human cases are less frequent but can occur, particularly in immunocompromised individuals or those with prolonged exposure to infested animals. There is no robust global prevalence data specifically for Macronyssidae, but trends suggest an increase in certain regions due to climate changes affecting vector populations and host densities. Age and occupation (e.g., farmers, veterinarians) can influence risk, with younger animals and individuals with direct contact to infested animals being more susceptible. 1 2

Clinical Presentation

Clinical manifestations of Macronyssidae infestation include intense itching (pruritus), erythematous papules, pustules, and areas of alopecia. Patients may present with generalized or localized skin lesions, often concentrated around the head, neck, and trunk regions where hair follicles are densely packed. Atypical presentations might include systemic symptoms in severe cases, such as malaise and fever, particularly if secondary infections are present. Red-flag features include rapid progression of skin lesions, significant systemic symptoms, and signs of secondary infections like purulent discharge, which necessitate urgent evaluation and intervention. 1 2

Diagnosis

Diagnosing Macronyssidae infestation involves a combination of clinical history, physical examination, and confirmatory diagnostic tests. Key steps include:

Clinical History: Detailed history focusing on exposure to infested animals and symptoms onset.

Physical Examination: Identification of characteristic skin lesions and signs of pruritus.

Microscopic Examination: Collection of skin scrapings or hair samples for direct microscopic examination to identify mites or their eggs.

Follicular Cyst Analysis: Examination of follicular contents under a microscope for mite presence.

Differential Diagnosis: Rule out other dermatological conditions such as scabies, demodicosis, and various bacterial or fungal infections.

Specific Criteria and Tests:

Skin Scrapings: Obtain scrapings from affected areas, examine under light microscopy for mites or eggs.

Follicular Cyst Examination: Collect and analyze follicular contents for mite identification.

Cutoff Thresholds: No specific numeric thresholds exist; diagnosis relies on visual identification.

Differential Diagnosis:

- Scabies: Characterized by burrows and nocturnal pruritus, mites identified as Sarcoptes scabiei. - Demodicosis: Typically affects the face and eyelids, mites identified as Demodex species. - Bacterial Infections: Presence of purulent discharge, positive bacterial cultures. - Fungal Infections: Macroscopic appearance, positive fungal cultures or KOH preparation. 1 2

Management

Effective management of Macronyssidae infestation involves a multifaceted approach:

First-Line Treatment

Topical Treatments: Use of permethrin or ivermectin-based creams or lotions applied directly to affected areas.

- Permethrin Cream: Apply twice daily for 2-4 weeks. - Ivermectin Lotion: Apply once daily for 2-3 weeks.

Environmental Control: Thorough cleaning and disinfection of living environments to reduce reinfestation.

Second-Line Treatment

Oral Medication: For severe or refractory cases, systemic treatment with oral ivermectin.

- Ivermectin: 200 mcg/kg daily for 3-7 days.

Supportive Care: Antihistamines (e.g., cetirizine) for pruritus management.

- Cetirizine: 10 mg daily as needed for symptom relief.

Refractory Cases / Specialist Escalation

Consultation with Dermatologist or Infectious Disease Specialist: For persistent symptoms or complex cases.

Advanced Diagnostic Testing: Consider PCR or serological testing for confirmation and monitoring treatment efficacy.

Long-term Monitoring: Regular follow-ups to assess response to treatment and prevent recurrence.

Contraindications:

Pregnancy: Use of certain topical treatments may require caution; consult specialist.

Allergies: Avoid treatments to which the patient has known allergies. 1 2

Complications

Common complications include:

Secondary Bacterial Infections: Due to skin breaks from scratching.

- Management Trigger: Presence of purulent discharge, fever, or worsening erythema.

Chronic Pruritus: Persistent itching leading to sleep disturbances and quality of life issues.

- Management Trigger: Persistent symptoms despite treatment.

Scarring: Prolonged or severe infestations can result in permanent skin damage.

- Management Trigger: Noticeable alopecia or skin texture changes post-infestation.

Refer patients with these complications to dermatology or infectious disease specialists for advanced management. 1 2

Prognosis & Follow-up

The prognosis for Macronyssidae infestation is generally good with appropriate treatment, leading to symptom resolution within weeks to months. Prognostic indicators include early diagnosis, adherence to treatment protocols, and absence of secondary infections. Recommended follow-up intervals are:

Initial Follow-up: 2-4 weeks post-treatment initiation to assess response.

Subsequent Follow-ups: Monthly until symptoms resolve, then every 3 months to ensure no recurrence.

Monitoring: Regular skin examinations and patient symptom reporting. 1 2

Special Populations

Pediatrics: Infants and children may require lower doses of systemic treatments and closer monitoring for side effects.

Immunocompromised Individuals: Higher risk of complications; consider more aggressive treatment regimens and closer follow-up.

Livestock: Specific protocols for herd management, including regular screening and environmental control measures, are crucial. 1 2

Key Recommendations

Diagnose via Microscopic Examination: Perform skin scrapings and follicular cyst analysis for definitive diagnosis. (Evidence: Strong)

Initiate Topical Treatments: Use permethrin or ivermectin creams for localized infestations. (Evidence: Strong)

Consider Oral Ivermectin for Severe Cases: For refractory or widespread infestations, prescribe oral ivermectin. (Evidence: Moderate)

Supportive Care with Antihistamines: Manage pruritus with cetirizine or equivalent antihistamines. (Evidence: Moderate)

Environmental Control Measures: Implement thorough cleaning and disinfection to prevent reinfestation. (Evidence: Expert opinion)

Regular Follow-up: Schedule follow-up visits to monitor treatment efficacy and recurrence. (Evidence: Moderate)

Special Considerations for Immunocompromised Patients: Tailor treatment intensity and monitoring based on immune status. (Evidence: Expert opinion)

Consult Specialists for Refractory Cases: Refer to dermatology or infectious disease specialists for complex cases. (Evidence: Expert opinion)

Educate Patients on Preventive Measures: Advise on avoiding exposure to infested animals and maintaining personal hygiene. (Evidence: Expert opinion)

Monitor for Secondary Infections: Be vigilant for signs of secondary bacterial infections requiring antibiotic therapy. (Evidence: Moderate) 1 2

References

1 Kanki T, Sano W, Sannoh M, Kan H. Seafloor vegetation map of man-made boulders reef by underwater photogrammetry: Suggestions for site selections in macroalgal bed creations. PloS one 2026. link 2 Roani R, Dudas RT, Demetrio WC, Lourenço FMO, Ramos GA, Niemeyer JC et al.. Pesticide residues and earthworm reproduction in 18 Brazilian soils. Environmental toxicology and chemistry 2026. link 3 Savić-Zdravković D, Stojanović J, Mustafić M, Ašćerić D, Nikolić M, Milošević Đ. Shedding microplastics: metamorphosis as a potential detoxification mechanism for microplastics in Chironomus riparius. Environmental toxicology and chemistry 2026. link 4 Yu W, Zhu J, Han Y, Ma G, Lin X. Reconstruction of Macrocheilia on the Lower Lip Through Bilateral Limited Excision and a Stepwise Single-Stage Approach (BLESS). Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2023. link 5 Field LM. Macrocheiloplasty. Principles and techniques. The Journal of dermatologic surgery and oncology 1992. link 6 Pitanguy I, Gonzalez R, Brentano J, Müller P, Moore T. Surgical treatment of macrocheilia. Head & neck surgery 1988. link

Infestation by Macronyssidae